REPLICEL LIFE SCIENCES INC. | CIK:0001205059 | 3

  • Filed: 5/11/2018
  • Entity registrant name: REPLICEL LIFE SCIENCES INC. (CIK: 0001205059)
  • Generator: Compliance Xpressware
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1205059/000106299318002112/0001062993-18-002112-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1205059/000106299318002112/repcf-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001205059
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfRelatedPartyExplanatory

    9.

    Related Party Transactions Related party balances

       
     

    The following amounts due to related parties are included in accounts payable and accrued liabilities:


          December 31, 2017     December 31, 2016     December 31, 2015  
      Companies controlled by directors of the Company $ 15,250   $ 15,250   $ 72,916  
      Directors or officers of the Company   294,447     232,491     142,887  
        $ 309,697   $ 247,741   $ 215,803  

    These amounts are unsecured, non-interest bearing and have no fixed terms of repayment.

    The Company incurred the following transactions with companies that are controlled by directors and/or officers of the Company. The transactions were measured at the exchange amount agreed to by the parties.

          December 31, 2017     December 31, 2016     December 31, 2015  
      Research and development $ 180,000   $ 1,535   $ 233,910  
      General and administration   33,000     -     -  
        $ 213,000   $ 1,535   $ 233,910  

    Key management compensation

    Key management personnel are persons responsible for planning, directing and controlling the activities of an entity, and include executive directors, the Chief Executive Officer and the Chief Financial Officer.

          December 31, 2017     December 31, 2016     December 31, 2015  
      General and administrative – salaries $ 240,000   $ 285,000   $ 578,887  
      Directors’ fees   55,000     55,000     42,137  
      Stock-based compensation   115,800     826,307     42,216  
        $ 410,800   $ 1,166,307   $ 663,240